Vical (VICL) 3.33 0.10

Vical, Inc.
(VICL) 3.33 0.10

Last Trade:	3.32	Day Range:	3.23 - 3.42
Trade Time:	12:02PM	52wk Range:	1.70 - 5.30
Prev. Close:	3.22	Market Cap:	238.65M
Open:	3.23	Div Yield:	0
Volume:	585334	PE:
EPS:	-0.10

The Latest On VICL

Notable Call Options Activity in Vical 2/8/12 10:18am

Vical Presents Case Study on Successful Design of Allovectin Phase 3 Melanoma Trial 1/30/12 6:38am

Vical Incorporated Prices Public Offering of Common Stock at $3.75 per Share 1/6/12 8:46am

Stocks To Watch For January 6 1/6/12 3:47am

Vical Incorporated (Nasdaq:VICL) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Citigroup, Credit Suisse Securities (USA) LLC and Leerink Swann LLC are acting as joint book-running managers 1/5/12 4:06pm

Vical Incorporated Announces Proposed Public Offering of Common Stock; No Size Given 1/5/12 4:06pm

Notable Call Options Activity in Vical 12/20/11 3:38pm

Weekly Homework: In Search Of The Santa Claus Rally (w/ Economic Calendar & Stock Radar) 12/11/11 11:22pm

Global Hunter Securities Initiates Buy, $9 PT on Vical Incorporated 12/1/11 10:56am

Global Hunter Initiates Vical at Buy, $9 PT 12/1/11 9:24am

Vical Breaks Out on High Volume 11/29/11 2:28pm

Notable Call Options Activity in Vical 2/8/12

Vical Presents Case Study on Successful Design of Allovectin Phase 3 Melanoma Trial 1/30/12

Vical Incorporated Prices Public Offering of Common Stock at $3.75 per Share 1/6/12

Stocks To Watch For January 6 1/6/12

Vical Incorporated Announces Proposed Public Offering of Common Stock; No Size Given 1/5/12

Notable Call Options Activity in Vical 12/20/11

Weekly Homework: In Search Of The Santa Claus Rally (w/ Economic Calendar & Stock Radar) 12/11/11

Global Hunter Securities Initiates Buy, $9 PT on Vical Incorporated 12/1/11

Global Hunter Initiates Vical at Buy, $9 PT 12/1/11

Vical Breaks Out on High Volume 11/29/11

Stocks To Watch For January 6 1/6/12

Weekly Homework: In Search Of The Santa Claus Rally (w/ Economic Calendar & Stock Radar) 12/11/11

Vical Breaks Out on High Volume 11/29/11

Top Percentage Gainers and Losers as of 2pm 5/12/11 (DSCO, OXGN, QCOR, QTWW, SNSS, RPTP, VICL, ORBK, PNSN, SPMD, CLWR, DEXO, CCIH, TNGN, NQ, SYMX, BAC, INTC) 5/12/11

List of Seven Cheap Biotech Stocks Expected to Grow, Seeking Alpha Reports (CHTP, TLON, HGSI, VNDA, OREX, SNTA, VICL) 4/28/11

Benzinga's Top Pre-Market NASDAQ Losers (VICL, FINL, CJBK, KUTV) 9/24/10

Benzinga's Top Pre-Market NASDAQ Losers (VICL, ADBE, PMCS, BIIB) 9/22/10

Benzinga’s Top Pre-Market Gainers (LIOX, SBCF, AUTH, NVAX, VICL) 4/22/10

Global Hunter Securities Initiates Buy, $9 PT on Vical Incorporated 12/1/11

Global Hunter Initiates Vical at Buy, $9 PT 12/1/11

Credit Suisse Initiating Coverage on Vical 11/4/11

Rodman & Renshaw Reiterates Market Outperform and PT of $6 on Vical 8/5/11

Rodman & Renshaw Reiterates Vical Market Outperform, $6 PT 7/15/11

Vical Downgraded to Hold (VICL) 9/22/10

Trade VICL
NOW!

Partner Headlines

Biotech Stock Mailbag: Vical, Hep C Drugs 1/27/12

5 Stocks With Big Insider Buying 1/12/12

Insiders Trading VICL, RAX, RAS, MIG 1/10/12

Two Biotech Stocks to Buy, One to Avoid 1/8/12

Vical, RF Micro: After-Hours Trading 1/5/12

Biotech Stock Mailbag: Most Important Events for 2012 12/23/11

Press Releases

Vical to Present at Upcoming Investor Conferences 2/13/12 GlobeNewswire Story

Vical Reports 2011 Financial Results and Progress in Key Development Programs 2/8/12 GlobeNewswire Story

Vical Announces News Release and Conference Call Schedule for 2011 Financial Results 2/2/12 GlobeNewswire Story

Vical Presents Case Study on Successful Design of Allovectin(R) Phase 3 Melanoma Trial 1/30/12 GlobeNewswire Story

Vical Provides Updates on CMV Vaccine Programs 1/11/12 GlobeNewswire Story

Vical to Present at Noble Financial Capital Markets Conference 1/10/12 GlobeNewswire Story

Vical Incorporated Prices Public Offering of Common Stock 1/6/12 GlobeNewswire Story

Vical Incorporated Announces Proposed Public Offering of Common Stock 1/5/12 GlobeNewswire Story

Vical to Present at Credit Suisse 2011 Healthcare Conference 11/2/11 GlobeNewswire Story

Vical Reports Third Quarter 2011 Financial Results and Progress in Key Development Programs 11/1/11 GlobeNewswire Story

Vical Reports Second Quarter 2011 Financial Results and Progress in Key Development Programs 8/30/11 GlobeNewswire Story

Vical to Present at NewsMakers Conference 8/30/11 GlobeNewswire Story

Get the latest VICL stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Vical, Inc. stock price.

Vical, Inc. by YCharts

Vical (VICL) 3.33 0.10

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On VICL

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social